Michael Moedritzer focuses his practice on domestic and international patent prosecution. He works with clients to revise, analyze and evaluate intellectual property-related issues to provide comprehensive overview of the portfolio.

Michael is a part of the Biotechnology and Life Sciences Patent Prosecution Group in Kansas City. After receiving his degree in Biological Sciences, Michael worked in academic research focusing on the genetics behind various embryonic facial malformations. He has experience in genetic engineering, molecular biology, and biochemical research.

Michael uses his experience in biochemical research and the legal field to assist clients with any of their intellectual property needs.

Education

  • University of Missouri-Columbia School of Law (J.D., cum laude, Order of the Coif, 2024)

    Bar Admission

    • Missouri

    Recognition

    • CALI Excellence for the Future Award for Advanced Patent Practice
    • CALI Excellence for the Future Award for Internet Law and Practice
    • CALI Excellence for the Future Award for Evidence
    Publications
    All Publications
    Polsinelli Life Sciences Spotlight - Volume 2 - Adapting by Design: Navigating Complex Times in Life Sciences
    We are pleased to share Volume 2 of our Life Sciences Spotlight report: Adapting by Design: Navigating Complex Times in Life Sciences. In today’s evolving landscape, companies must be prepared to meet complexity with clarity and agility. This edition explores the strategies, insights and innovations enabling industry leaders to adapt — with purpose: Pharma Tariffs are Coming - Are You Ready? End of Lifecycle Challenge for Biologics: How to Avoid the Pitfalls Near the End of Exclusivity Q&A with VivoSim CEO Keith Murphy The Rising Threat of Brand Abuse — and How Life Sciences Companies Can Respond PFAS Regulations Impacting the Life Sciences Industry BIO Week in Boston: Highlights & Takeaways  Join Us During Biotech Week Boston 2025  Explore the full report to see what’s shaping the future and
    Read More
    Freedom to Operate: What It Is and Why Your Startup Can’t Afford to Ignore It
    Michael Moedritzer, an attorney in our Biotech & Life Science Patent Prosecution Group, discusses what an FTO opinion is, why founders need it and how to secure one.
    Read More